Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant vs Gabapentin for PONV in laparoscopic gynecological surgery
NCT02525848Phase 3Completed
- Sponsor
- Assiut University
- Start
- Aug 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aprepitant, gabapentin in postoperative nausea and vomiting (PONV), sponsored by Assiut University. Started Aug 2015; status: completed.
02
Drugs
aprepitantgabapentin
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02525848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02525848.